Key result
Computational modeling-guided virtual Smax ablation did not reduce the clinical recurrence of atrial tachyarrhythmia compared to empirical ablation in patients with persistent atrial fibrillation.
Why the study?
It was unknown whether extra-pulmonary vein ablation targeting a high maximal slope of the action potential duration restitution curve improves rhythm outcomes in persistent atrial fibrillation ablation.
Does computational modeling-guided virtual Smax ablation improve freedom from atrial tachyarrhythmia recurrence in patients with persistent atrial fibrillation compared to empirical ablation?
RCT (n=178)
Single-blind
1:1
Yes
Does computational modeling-guided virtual Smax ablation improve freedom from atrial tachyarrhythmia recurrence in patients with persistent atrial fibrillation compared to empirical ablation?
Computational modeling-guided virtual Smax ablation did not improve rhythm outcomes compared to empirical ablation in patients with persistent atrial fibrillation and resulted in longer procedure times.
Answers are grounded in this paper and cite their sources.
Virtual Smax ablation offers no recurrence benefit over empirical ablation in persistent AF; does not support its adoption and questions modeling-guided strategies.
BACKGROUND AND OBJECTIVES: We investigated whether extra-pulmonary vein (PV) ablation targeting a high maximal slope of the action potential duration restitution curve (Smax) improves the rhythm outcome of persistent atrial fibrillation (PeAF) ablation. METHODS: In this open-label, multi-center, randomized, and controlled trial, 178 PeAF patients were randomized with 1:1 ratio to computational modeling-guided virtual Smax ablation (V-Smax) or empirical ablation (E-ABL) groups. Smax maps were generated by computational modeling based on atrial substrate maps acquired during clinical procedures in sinus rhythm. Smax maps were generated during the clinical PV isolation (PVI). The V-Smax group underwent an additional extra-PV ablation after PVI targeting the virtual high Smax sites. RESULTS: After a mean follow-up period of 12.3±5.2 months, the clinical recurrence rates (25.6% vs. 23.9% in the V-Smax and the E-ABL group, p=0.880) or recurrence appearing as atrial tachycardia (11.1% vs. 5.7%, p=0.169) did not differ between the 2 groups. The post-ablation cardioversion rate was higher in the V-Smax group than E-ABL group (14.4% vs. 5.7%, p=0.027). Among antiarrhythmic drug-free patients (n=129), the AF freedom rate was 78.7% in the V-Smax group and 80.9% in the E-ABL group (p=0.776). The total procedure time was longer in the V-Smax group (p=0.008), but no significant difference was found in the major complication rates (p=0.497) between the groups. CONCLUSIONS: Unlike a dominant frequency ablation, the computational modeling-guided V-Smax ablation did not improve the rhythm outcome of the PeAF ablation and had a longer procedure time. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02558699.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2022) conducted an RCT in Persistent atrial fibrillation (n=178). Computational modeling-guided virtual Smax ablation (V-Smax) vs. Empirical ablation (E-ABL) was evaluated on Clinical recurrence of atrial tachyarrhythmia (p=0.880). Computational modeling-guided virtual Smax ablation did not reduce the clinical recurrence of atrial tachyarrhythmia compared to empirical ablation in patients with persistent atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: